维普中文期刊产品整合服务
46篇 您的检索式:作者名="Albany C"
    题名 作者 年代 出处 被引量
1Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial显示文摘Kris V Kowdley Eric Lawitz Israel Crespo Tarek Hassanein Mitchell N Davis Michael DeMicco David E Bernstein Nezam Afdhal John M Vierling Stuart C Gordon Jane K Anderson Robert H Hyland Hadas Dvory-Sobol Di An Robert G Hindes Efsevia Albanis William T Symo 2013The Lancet2013,,9883:3
2卒中介入治疗培训指南:国际多学会共识文件显示文摘1背景 缺血性卒中是全球人口死亡和残疾的首要原因。很多急性大血管闭塞(emergent large vesselocclusion,ELVO)患者都会遗留长期残疾。事实上,这些颅内大动脉闭塞经常会导致大面积脑损伤,进而造成患者死亡或严重致残。Lavine SD Cockroft K Hoh B Bambakidis N Khalessi AA Woo H Riina H Siddiqui A Hirsch JA Chong W Rice H Wenderoth J Mitchell P Coulthard A Signh TJ Phatorous C Khangure M Klurfan P ter Brugge K Iancu D Gunnarsson T Pongpech S Rodesch G Soderman M Taylor A Krings T Orbach D Picard L Suh DC Zheng HQ Jansen O Muto M Szikora I Pierot L Brouwer P Gralla J Renowden S Andersson T Fiehler J Turjman F White P Januel AC Spelle L Kulcsar Z Chapot R Biondi A Dima S Taschner C Szajner M Krajina A Sakai N Matsumaru Y Yoshknura S Ezura M Fujinaka T Iihara K Ishii A Higashi T Hirohata M Hyodo A Ito Y Kawanishi M Kiyosue H Kobayashi E Kobayashi S Kuwayama N Matsumoto Y Miyachi S Murayama Y Nagata I Nakahara I Nemoto S Niimi Y Oishi H Satomi J Satow T Sugiu K Tanaka M Terada T Yamagami H Diaz O Lylyk P Jayaraman MV Patsalides A Gandhi CD Lee SK Abruzzo T Albani B Ansari SA Arthur AS Baxter BW Bulsara KR Chen M Almandoz JE Fraser JF Heck DV Hetts SW Hussain MS Klucznik RP Leslie-Mawzi TM Mack WJ McTaggart RA Meyers PM Mocco J Prestigiacomo CA Pride GL Rasmussen PA Starke RM Sunenshine PJ Tarr RW Frei DF Pabo M Nogueira RG Zaidat OO Jovin T Linfante I Yavagal D Liebeskind D Novakovic R Pongpech S 许岩 孙瑞 郭芮兵 2017国际脑血管病杂志2017,25,5:2
3Randomized, double-blind ,placebo-controlle, phase BI cross-over study evaluatingthe oral neurokinin-1 antagonist aprepitant in combination witha5HT3 receptor antagonist and dexamethasone in patients with ger-mcell tumors receiving 5-day cisplatin combination chemotherapyregimens : a hoosier oncology group study 显示文摘Albany C Brames MJ Fausel C 2012J Clin Oncol2012,30,32:1
4PCR amplification of microdissected wheat chromosome arms in a simple'single tube'reaction显示文摘Albani D Cote M J Armstrong K C 1993Plant J1993,4,5:1
5Randomized, double-blind,placebo-controlled, phase III cross-over study evaluating the oralneurokinin-1antagonist aprepitant in combination with a 5HT3 receptorantagonist and dexamethasone in patients with germ cell tumors receiving5-day cisplatin combination chemotherapy regimens: a hosier oncologygroup study显示文摘Albany C1 Brames MJ Fausel C 2012J ClinOncol2012,30,32:1
6Randomized, doubleblind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-l antagonist aprepitant in combination with a 5 HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study显示文摘Albany C Brames MJ Fausel C 2012J Clin Oncol2012,30,32:1
7The wheat transcriptional activator SPA: a seed - specific bZIP protein that recognizes the GCN4 - like motif in the bifactorial endosperm box of prolamin genes显示文摘Albani D Hammond - Kosack M C Smith C 1997Plant Cell1997,9,2:1
8Manage- ment and follow-up of impacted ureteral stones 显示文摘Deliveliotis C Chrisofos M Albanis S 2003Urol Int2003,70,4:1
9Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5-HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study显示文摘Albany C Brames MJ Fausel C 2012J Clin Oncol2012,30,32:1
10Fatigue assessment questionnaire:standardization of a cancer-specific instrument based on the general population显示文摘Beutel M E Hinz A Albani C 2006Oncology2006,70,5:1
11Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece显示文摘KOSMA C I LAMBROPOULOU D A ALBANIS T A 2010Journal of Hazardous Materials2010,179,1:1
12Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation显示文摘Hasenbein W Albani J Englert C 2006Pediatr Transplant2006,10,8:1
13Randomized, dou- ble-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexa- methasone in patients with germ cell tumors receiving 5- day cisplatin combination chemotherapy regimens: a hoosier oncology group study显示文摘Albany C Brames M J Fausel C 2012J Clin Oncol2012,30,32:1
14PCR amplification of microdissected wheat chromosome arms in a simple single tube reaction 显示文摘Albani D Cote M J Armstrong K C 1993Plant J1993,4,:1
15Aa TFL1 con- fers an age dependent response to vernalization in perennial Ara- bis alpine 显示文摘WANG R ALBANI M C VINCENT C BERGONZI S LUAN M BAI Y KIEFER C CASTILLO R COUPLAND G 2011The Plant Cell2011,23,4:1
16Lung cancer,thyroid cancer or both:An unusual case presentation显示文摘Albany C Jain A Ulbright TM 0,,04:1
17APOE n2 and 4 influ- ence the susceptibility for Alzheimer's disease but not other de- mentias显示文摘Lovati C Galimberti D Albani D 2010Int J Mol Epidemiol Genet2010,1,3:1
18Management of chemotherapy induced nausea and vomiting in patients on multiday cisplatin based combination chemotherapy 显示文摘Ranganath P Einhorn L Albany C 2015Biomed Ees Int2015,,94:1
19The development of ISSR-derived SCAR markers around the seasonal flowering locus(SFL) in Fragaria vesca显示文摘Albani M C Battery N H Wilkinson M J 2004Theor Appl Genet2004,109,3:1
20Extragonadal germ cell tumors : clinicalpr- esentation and management显示文摘Albany C Einhorn LH 2013Curr Opin Oncol2013,25,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费